The counting of microvessels in tumors has demonstrated
|
|
- Pierce Bryant
- 5 years ago
- Views:
Transcription
1 Tumor Angiogenesis and Recurrence in Stage I Non-Small Cell Lung Cancer Yasuhiko Ohta, MD, Yoshiharu Tomita, MD, Makoto Oda, MD, Shunichi Watanabe, MD, Shinya Murakami, MD, and Yoh Watanabe, MD First Department of Surgery, Kanazawa University School of Medicine, Kanazawa, Japan Background. Tumor angiogenesis appears to relate to recurrence after an operation as a route for distant metastasis. We assessed the association of vascular endothelial growth factor (VEGF) expression and intratumoral microvessel density (MD) with recurrence in primary lung cancer. Methods. Samples were randomly obtained from 104 stage I lung cancer patients who underwent curative operations (43 recurrent, 61 nonrecurrent patients). Microvessels were highlighted by staining endothelial cells for factor VIII and VEGF antigen was detected using a polyclonal antibody. Results. VEGF antigen was detected in large amounts in both recurrent (%) and nonrecurrent tumors (73.8%). The percentages of patients with the strongest VEGF stain (more than 50% of staining area in tumor cells) were 46.5% in tumors with recurrence and 11.5% in tumors without recurrence. The mean MD in recurrent and nonrecurrent tumors were and , respectively, resulting in a significantly greater value in tumors with recurrence (p < ). Although there were no significant differences in mean MD according to pathological types, in adenocarcinoma and adenosquamous carcinoma, the mean value in the recurrent group was significantly greater than that in the nonrecurrent one. Conclusions. An evaluation of VEGF expression and MD in tumors may contribute to the estimation of the risk of recurrence of non-small cell lung cancer in early stages. (Ann Thorac Surg 1999;68:1034 8) 1999 by The Society of Thoracic Surgeons The counting of microvessels in tumors has demonstrated a close relationship between vascularization and poor clinical prognosis in non-small cell lung cancer [1, 2]. Although there are a few studies to the contrary [3, 4], tumor angiogenesis is not only an integral step for tumor growth [5] but is also directly associated with tumor invasion [6]. In addition neovascularization, as a route for distant metastasis, appears to be related to recurrence after an operation. Theoretical simulations have shown that tumors with rich neovascularization are likely to have a high risk of distant metastasis that causes recurrence in some time intervals according to the acquisition of angiogenic ability in metastatic tumor cells. After curative operations, about 30% 40% of non-small cell lung cancer patients in stage I have been suffering from recurrence. This study focuses on the assessment of tumor angiogenesis in stage I non-small cell lung cancer with or without recurrence by highlighting the impact of vascular endothelial growth factor (VEGF) expression and microvessel density (MD) in tumors on the risk of recurrence after an operation. Accepted for publication March 22, Address reprint requests to Dr Ohta, First Department of Surgery, Kanazawa University School of Medicine, Takara-machi 13-1, Kanazawa , Japan; yohta@med.kanazawa-u.ac.jp. Patients and Methods Tumor samples were randomly obtained from 104 primary lung cancer patients in stage I who received curative operations with routine systematic nodal dissection of both the hilar and the mediastinal lymph nodes as previously described [7, 8] in Kanazawa University Hospital from 1988 to In follow-up periods longer than 5 years, 43 patients died from recurrent lung cancer and 61 patients survived without any recurrence. In the recurrent group (n 43), the 34 men and 9 women had a mean age of years (range, 52 to 80 years). The operative procedures were 39 lobectomies, 3 bilobectomies, and 1 pneumonectomy with systematic nodal dissection. The pathological types were twenty-six adenocarcinomas, eleven squamous cell carcinomas, five adenosquamous carcinomas, and one large cell carcinoma. According to TNM classification [9], 24 patients were in stage IA (T1N0M0) and 19 were in stage IB (T2N0M0). The median survival was 106 months (3 151 months) in this group. On the other hand, in the nonrecurrent group (n 61), 53 lobectomies, 6 bilobectomies, and two pneumonectomies with systematic nodal dissection were done in 38 men and 23 women, with a mean age of years (range 47 to 76). The pathological types were twenty-eight adenocarcinomas, twenty squamous cell carcinomas, nine adenosquamous carcinomas, one large cell carcinoma, one adenoid cystic carcinoma, and two carcinoid tumors. Fifty-one patients were in stage IA and 10 patients were in stage IB. The mean follow-up 1999 by The Society of Thoracic Surgeons /99/$20.00 Published by Elsevier Science Inc PII S (99)
2 Ann Thorac Surg OHTA ET AL 1999;68: ANGIOGENESIS AND RECURRENCE IN LUNG CANCER 1035 Table 1. Basic Clinical Background Factors of the 104 Lung Cancers in Stage I Who Underwent Curative Resection Characteristics Recurrent Patients period was 106 months ( months) in this group. The basic clinical features of the patients are summarized in Table 1. The recurrent group had relatively larger amount of patients with T2 (stage IB) compared to the nonrecurrent one (p ). Immunohistochemistry and the Assessment of Microvessel Density in Tumors Non-Recurrent Patients No. of patients Mean age Male:Female 34:9 38:23 Tumor size T1 ( 3 cm) T2 ( 3 cm) Histology Adenocarcinoma Squamous cell carcinoma Adenosquamous carcinoma 5 9 Others 1 4 After reviewing the hematoxylin and eosin-stained slides of the tumor specimens, we selected blocks of the invasive edge in the tumor area. Expressions of VEGF were assessed by immunohistochemical staining, which has been described previously [10]. Briefly, the paraffinembedded tumor tissue was sectioned into a thickness of 3 m, then sections were deparaffinized with xylene and dehydrated with 98% ethyl alcohol at 37 C. Endogenous peroxidase was blocked by treatment with 0.3% hydrogen peroxide in methanol for 20 minutes and specimens were washed with Dulbecco phosphate-buffered saline (ph 7.2) without calcium and magnesium ion (PBS ). These sections were incubated with normal goat serum diluted 10-fold with PBS for 15 minutes at room temperature for blocking. After being washed with PBS, the sections were reacted with anti-vegf polyclonal antibody (Santa Cruz Biotechnology Inc, Heidelberg, Germany) diluted -fold with PBS containing 1% bovine serum albumin for 24 hours at 4 C. They were then washed with PBS, and reacted with biotin-labeled goat anti-mouse immunoglobulin (DAKO Corporation, Carpinteria, CA) for 2 hours. After they were washed with PBS, avidin-biotin-peroxidase complex was added and color was developed by 3 3 diaminobenzidine (Sigma, St. Louis, USA) with 0.03% hydrogen peroxide. Counterstaining was done with methyl green. Negative control used all reagents except for the primary antibody. It was considered to be positive staining when more than 10% of the tumor area was stained. The immunoreactivities were graded as ( ), ( ), and ( ) according to the staining intensity of the tumor cells: ( ) represents zero or less than 10% of positive staining area, ( ) represents 10% 50% of positive staining area, and ( ) represents the strongest stain more than 50% at 200 magnification. To assess MD in tumors, the primary antibody used was a rabbit polyclonal antibody (DAKO, Carpinteria, CA) at a 1:200 dilution for factor VIII. Following predigestion and trypsinization, immunohistochemical staining was done by the same immunoperoxidase technique as described above. Vessel counting was done without any knowledge of clinical information. After scanning all tumor sections at low power magnification ( 40), 3 areas with the highest microvessel density were identified. Vessel counts from 3 areas were averaged and MD was defined. In regard to counting, the authors followed the criteria described by Weidner and associates [11]. Statistics Differences in microvessel densities were analyzed using the Mann-Whitney U test. The association between other different valuables was analyzed by the chi-square test. MD, VEGF, age, gender, and T-factor were included in the assessment of prognostic indicators. MD and age were classified as high or low group relative to the median value of each parameter. For VEGF, a tumor was included in VEGF overexpressing group if positive staining area in tumor cells was greater than 50%. Survival curves were obtained by the Kaplan-Meier method, and compared univariately by the log-rank test. For multivariate analysis, the Cox proportional hazard regression along with a stepwise procedure was used. The criterion for statistical significance was p 0.05 and the mean values were shown with SD. Results The 3- and 5-year survival rates for the patients in the recurrent group (n 43) were 34.9% and 14.0%, respectively, having a significantly worse prognosis as compared to those (both %) in the nonrecurrent group (p 0.01). The percentage of VEGF positive tumors and that of tumors with the strongest VEGF stain (more than 50% of the staining area in tumor cells) were 88.9% (48 of 54) and 29.6% (16 of 54) in adenocarcinomas, 80.6% (25 of 31) and 16.1% (5 of 31) in squamous cell carcinomas, and 85.7% (12 of 14) and 21.4% (3 of 14) in adenosquamous carcinomas. As a whole, VEGF antigen was detected in large amounts in both recurrent (%) and nonrecurrent groups (73.8%). In particular, the percentage of patients with the strongest VEGF stain were 46.5% (20 of 43) in the recurrent group and only 11.5% (7 of 61) in the nonrecurrent one (Table 2) (). The mean MD in the recurrent and nonrecurrent tumors were and , respectively. The tumors in the recurrent group had a significantly greater MD compared to that in the nonrecurrent group (p ) (Table 2). According to the pathological types, mean MD was in adenocarcinoma, in squamous cell carcinoma, and in adenosquamous carcinoma. The mean MD in recurrent and non-recurrent groups were vs (p
3 1036 OHTA ET AL Ann Thorac Surg ANGIOGENESIS AND RECURRENCE IN LUNG CANCER 1999;68: Table 2. Microvessel Density and Vascular Endothelial Growth Factor Expression in Tumors With or Without Recurrence, and Their Correlation With Tumor Size Variables Mean Microvessel Density Standard Deviation Positive Stain b Vascular Endothelial Growth Factor Expression (%) a Strongest Stain c Total Recurrent group (n 43) p Nonrecurrent group (n 61) Total (n 104) Tumor size T1 ( 3 cm) (n 75) p p T2 ( 3 cm) (n 29) Recurrent group T1 ( 3 cm) (n 24) p T2 ( 3 cm) (n 19) Non-recurrent group T1 ( 3 cm) (n 51) p p T2 ( 3 cm) (n 10) p p p a Percentage of patients with positive VEGF stain. b More than 10% of positive staining area in tumor cells. c More than 50% of positive staining area in tumor cells ) in adenocarcinomas, vs (p 0.772) in squamous cell carcinomas, and vs (p ) in adenosquamous carcinomas. Particularly in adenocarcinoma and adenosquamous carcinoma, the mean MD in tumors and the percentage of patients with the strongest VEGF stain in the recurrent group were significantly greater than those in the nonrecurrent group (Table 3). In total, T2 (stage IB) tumors had higher MD and VEGF expression than T1 (stage IA) tumors. However, when tumors were classified into recurrent or nonrecurrent group, no significant differences were found in each group (Table 2). In univariate analysis, high MD (p ), overexpression of VEGF (), and T2 (p ) correlated with poor survival. Gender (male) also tended to be associated with poor survival (p ). Multivariate analysis revealed independent prognostic impact of MD, VEGF overexpression, and T-factor on overall survival. The prognostic impact of MD and VEGF overexpression were greater than that of T-factor (Table 4). Comment In non-small cell lung cancer, Macchiarini and associates [1] first observed a relationship between neovasculariza- Table 3. The Mean Microvessel Density and Vascular Endothelial Growth Factor Expression in Tumors of Each Pathological Type Pathological Type Mean Microvessel Density Standard Deviation Positive Stain b Vascular Endothelial Growth Factor Expression (%) a Strongest Stain c Adenocarcinoma Recurrent group (n 26) p Nonrecurrent group (n 28) Total (n 54) Squamous cell carcinoma Recurrent group (n 11) p p Nonrecurrent group (n 20) Total (n 31) Adenosquamous carcinoma Recurrent group (n 5) p p Nonrecurrent group (n 9) Total (n 14) p p p a Percentage of patients with positive VEGF stain. b More than 10% of positive staining area in tumor cells. c More than 50% of positive staining area in tumor cells.
4 Ann Thorac Surg OHTA ET AL 1999;68: ANGIOGENESIS AND RECURRENCE IN LUNG CANCER 1037 Table 4. Cox Proportional Hazard Regression Analysis Variables Hazard Ratio p Value 95% CI Microvessel density Vascular endothelial growth factor T-factor Gender a A tumor was included if positive staining area in tumor cells was more than 50%. CI confidence interval. tion and metastasis in In 1994, Yamazaki and associates [2] found that angiogenesis, which was assessed by counting microvessels in lung adenocarcinomas, was positively correlated with the relapse of patients after an operation, and they also suggested that microvessel counts in tumors were associated with the aggressiveness of the tumor. Since then, multiinstitutional research has assessed the impact of MD in tumors on the prognosis in primary lung cancer, and some researchers have found that MD has a close relationship to poor prognosis in assessment via overall survival or disease free intervals [12, 13]. In this study, we assessed MD in tumors from both recurrent and nonrecurrent lung cancer patients in stage I. As a result, it was clearly found that the mean MD in tumors with recurrence was significantly greater than that in tumors without recurrence, indicating the participation of neovascularization within tumors in the metastatic event and recurrence in lung cancer. In addition, this study provides further evidence that the impact of MD on the risk of recurrence appears to be different between pathological types. That is, the mean MD in tumors with recurrence was significantly greater than that in tumors without recurrence in adenocarcinoma and adenosquamous carcinoma, but no significant differences were found in squamous cell carcinoma. This implies that the metastatic behavior associated with angiogenesis appears to be different between cancer cell types and, as a route of metastasis, neovessels may be much more important for adenocarcinoma and adenosquamous carcinoma cells than for squamous cell carcinomas in lung cancer. These relations should be further explored in other data sets together with the evaluation of advanced cases alike. VEGF is an endothelial cell-specific powerful mitogen that is associated with tumor neovascularization. The positive relationship between VEGF expression and MD has already been observed in a variety of tumors. It is of interest that lung alveoli are originally organs with rich VEGF expression [14]. In this intrinsic condition that may promote malignant development, some studies have elucidated the poor outcome of lung cancer patients with strong VEGF expression in tumors [3, 10, 15]. In this study, we did not address the VEGF expression in surrounding normal lung tissue. From the basic data, using reverse transcription-pcr for the specific and sensitive detection of VEGF gene expression however, we have already confirmed that VEGF expression levels in lung cancer tissue are significantly greater than that in correspondent surrounding normal lung tissue with expression of the dominant types of VEGF121 and 165 among the 4 alternatively spliced variants (data not shown). And we previously reported that the VEGF gene expression levels might be a significant prognostic indicator of the early stages of lung cancer [10]. The recent data also demonstrated that VEGF expression was an independent prognostic indicator in lung cancer patients based on the immunohistochemistry [15, 16]. In this study, we could ascertain the independent prognostic impact of VEGF together with MD on overall survival in stage I non-small cell lung cancer patients. With our previous findings that indicated a significant correlation between VEGF expression and lymph node metastasis in primary lung cancer, we believe that VEGF expression is associated not only with blood distant metastasis but also with lymphatic metastasis through neo-blood and lymphatic vessels in lung cancer [17]. Although the type of recurrence could not be precisely determined in this study, the VEGF expression as detected by immunohistochemistry revealed a high percentage of the strongest VEGF stain (more than 50% of the staining area in tumor cells) in tumors with recurrence compared with that in tumors without recurrence. The overexpression of VEGF in tumors appears to be associated with recurrence. In conclusion, we have shown that the mean MD and VEGF expression in tumors with recurrence was significantly greater than those in tumors without recurrence in stage I non-small cell lung cancer, and their prognostic impact was greater than that of T-factor. The evaluation of neovascularization in tumors may contribute to the estimation of the risk of recurrence of non-small cell lung cancer in early stages, especially for adenocarcinoma and adenosquamous carcinoma. References 1. Macchiarini P, Fontanini G, Hardin MJ, et al. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 1992;340: Yamazaki K, Abe S, Takekawa H, et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1994;74: Mattern J, Koomagi R, Volm M. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int J Oncol 1995;6: Chandrachud LM, Pendleton N, Chisholm DM, et al. Relationship between vascularity, age and survival in non-smallcell lung cancer. Br J Cancer 1997;76: Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339: Skobe M, Rockwell P, Goldstein N, et al. Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 1997;3: Watanabe Y, Shimizu J, Oda M, et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg 1991;51: Watanabe Y, Shimizu J, Tsubota M. Mediastinal spreads of metastatic lymph nodes in bronchogenic carcinoma. Chest 1990;97: Sobin LH, Wittekind C. TNM classification of malignant tumours. New York:Wiley-Liss, 1997.
5 1038 OHTA ET AL Ann Thorac Surg ANGIOGENESIS AND RECURRENCE IN LUNG CANCER 1999;68: Ohta Y, Endo Y, Tanaka M, et al. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res 1996;2: Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324: Fontanini G, Bigini S, Vignati S. Microvessel count predict metastatic disease and survival in non-small cell lung cancer. J Pathol 1995;177: Giatromanolaki A, Koukourakis M, O Byrne K, et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 1996;179: Berse B, Brown LF, Water LVD, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3: Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997;3: Volm M, Rittgen W, Drings P. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer 1998;77: Ohta Y, Watanabe Y, Murakami S, et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br J Cancer 1997;76: The Thoracic Surgery Foundation for Research and Education Robert Wood Johnson Foundation Educational Opportunities The Thoracic Surgery Foundation announces two opportunities for cardiothoracic surgeons to apply for educational experiences sponsored by the Robert Wood Johnson Foundation. There are indications of interest in having cardiothoracic surgeons apply for the Clinical Scholars Program and/or the Washington, DC-based Fellowships for Mid-Career Health Professionals. 1. The Robert Wood Johnson Clinical Scholars Program is designed to allow young physicians committed to clinical medicine to acquire new skills and training in the non-biological sciences important to medical care systems. The program offers months of graduate level study and research as part of a university-based, postresidency training program. At least 20% of the Clinical Scholars time is spent in relevant clinical activities as part of their experiences. The Robert Wood Johnson Foundation has supported the Clinical Scholars Program since Currently, seven institutions participate in the program and will be recruiting Scholars to begin the program in July These institutions are: the University of California, Los Angeles; the University of Chicago; the Johns Hopkins University; the University of Michigan; the University of North Carolina, Chapel Hill; the University of Washington, Seattle; and Yale University. At each of these university sites, a study and research program is tailored to meet the Scholar s specific interests within the priority area the Scholar selects. Faculty and resources are available in a broad array of disciplines, including epidemiology, biostatistics, medical information sciences, economics, the social sciences, anthropology, history of medicine, law, ethics, and the humanities. Although the programs vary in design and emphasis, each has developed core programs to introduce Scholars to basic non-biological disciplines and methods used in health care research. The Clinical Scholars Program will give cardiothoracic surgeons research tools which can be used over their entire careers. 2. RWJ Health Policy Fellows mid-career health professionals from academic and community health settings nationwide spend nearly a year in Washington, DC, learning first-hand how the health policy process works. Fellows have an extensive orientation, which brings them into contact with key policy leaders in the nation s capital and prepares them for their nine-month work assignments with members of Congress or the executive branch. In recent years, these assignments have covered the breadth of the political spectrum in health policy including the offices of Senators Dole (R-KS), Rockefeller (D-WV), Hatch, (R-UT), Kassebaum (R-KS) and Kerrey (D-NE). The Fellows consistently report that the program has had an enormous influence on their careers. Even when they don t work directly in policy afterwards, they are much better able to help their colleagues and home institutions to understand the interplay of forces that is drastically changing our nation s health system. This is the pinnacle, introductory experience to how our political system works regarding health care. Both programs are extraordinarily prestigious and will have continuing meaning for the careers of successful candidates. For further details and stipend information on these RWJ programs, contact The Thoracic Surgery Foundation office: Phone: ; Fax: ; Frank_Kurtz@SBA.com by The Society of Thoracic Surgeons Ann Thorac Surg 1999;68: /99/$20.00 Published by Elsevier Science Inc
Surgery remains the mainstay treatment for localized
Surgical Results in T2N0M0 Nonsmall Cell Lung Cancer Patients With Large Tumors 5 cm or Greater in Diameter: What Regulates Outcome? Yasuhiko Ohta, MD, Ryuichi Waseda, MD, Hiroshi Minato, MD, Naoki Endo,
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More informationVisceral pleural involvement (VPI) of lung cancer has
Visceral Pleural Involvement in Nonsmall Cell Lung Cancer: Prognostic Significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu, MD, PhD, Sosuke Yamada, MD, and Kosei Yasumoto,
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationT umour neoangiogenesis has recently been recognised to
591 ORIGINAL ARTICLE Prognostic impact of,, CD34, and expression and tumour vessel invasion after radical surgery for IB IIA non-small cell lung cancer T C Mineo, V Ambrogi, A Baldi, C Rabitti, P Bollero,
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationAlthough metastasis in regional lymph nodes is one of
Nodal Occult Metastasis in Patients With Peripheral Lung Adenocarcinoma of 2.0 cm or Less in Diameter Jian Wu, MD, Yasuhiko Ohta, MD, Hiroshi Minato, MD, Yoshio Tsunezuka, MD, Makoto Oda, MD, Yoh Watanabe,
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationAlthough ipsilateral intrapulmonary metastasis (PM), Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis
Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis Morihito Okada, MD, Noriaki Tsubota, MD, Masahiro Yoshimura, MD, Yoshifumi Miyamoto, MD, and Reiko Nakai,
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationPrognostic Significance of Extranodal Cancer Invasion of Mediastinal Lymph Nodes in Lung Cancer
Jpn. J. Clin. Oncol. 198, 1 (), 7-1 Prognostic Significance of Extranodal Cancer Invasion of Mediastinal Lymph Nodes in Lung Cancer KEIICHI SUEMASU, M.D. AND TSUGUO NARUKE, M.D. Department of Surgery,
More informationTumor Angiogenesis in Stage II Colorectal Carcinoma Association With Survival
ANATOMIC PATHOLOGY Original Article Tumor Angiogenesis in Stage II Carcinoma Association With Survival BARBARA F. BANNER, MD, ROB WHITEHOUSE, STEPHEN P. BAKER, MSPH, AND RICHARD S. SWANSON, MD We studied
More informationExtent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationLymph node dissection for lung cancer is both an old
LOBE-SPECIFIC EXTENT OF SYSTEMATIC LYMPH NODE DISSECTION FOR NON SMALL CELL LUNG CARCINOMAS ACCORDING TO A RETROSPECTIVE STUDY OF METASTASIS AND PROGNOSIS Hisao Asamura, MD Haruhiko Nakayama, MD Haruhiko
More informationOriginal Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical outcome
Int J Clin Exp Pathol 2017;10(2):2030-2035 www.ijcep.com /ISSN:1936-2625/IJCEP0009456 Original Article CREPT expression correlates with esophageal squamous cell carcinoma histological grade and clinical
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationVascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis
Original papers Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis Aydan Eroğlu 1, A F, Cevriye Ersöz 2,
More informationNumber of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival
Number of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD, Dae Joon Kim, MD, Seong Yong Park, MD, Kil Dong Kim,
More informationMediastinal Spread of Metastatic Lymph Nodes in Bronchogenic Carcinoma*
Mediastinal Spread of Metastatic Lymph Nodes in Bronchogenic Carcinoma* Mediastinal Nodal Metastases in Lung Cancer Yoh Watanabe, M.D., F.C.C.P.; ]unzo Shimizu, M.D.; Makoto Tsubota, M.D.; and Takashi
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationPulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy
European Journal of Cardio-Thoracic Surgery 41 (2012) 25 30 doi:10.1016/j.ejcts.2011.04.010 ORIGINAL ARTICLE Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy
More informationHypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients
Journal of BUON 17: 663-668, 2012 2012 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor
More informationHigh expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.
Biomedical Research 2017; 28 (18): 7779-7783 ISSN 0970-938X www.biomedres.info High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer. Hu Song 1, Qi-yu Liu 2, Zhi-wei
More informationVisceral pleura invasion (VPI) was adopted as a specific
ORIGINAL ARTICLE Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database Junji Yoshida,
More informationIntraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer
Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer Yasushi Shintani, MD, hd, a Mitsunori Ohta, MD, hd, a Teruo Iwasaki, MD, hd, a Naoki
More informationSurgical resection is the first treatment of choice for
Predictors of Lymph Node and Intrapulmonary Metastasis in Clinical Stage IA Non Small Cell Lung Carcinoma Kenji Suzuki, MD, Kanji Nagai, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, and Yutaka Nishiwaki,
More informationObject Localization Procedure for Intratumoral Microvessel Density Estimation
Object Localization Procedure for Intratumoral Microvessel Density Estimation OVIDIU GRIGORE ANDRE PUGA Telecommunications and Multimedia Department INESC Porto Praça da Republica 93, 4050-497 Porto PORTUGAL
More informationThe accurate assessment of lymph node involvement is
ORIGINAL ARTICLE Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification? Shenhai Wei, MD, PhD,*
More informationCharacteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu
ORIGINAL ARTICLE Characteristics of intramural metastasis in gastric cancer Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu Hishima Author for correspondence: T. Hashimoto
More informationCharacterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma
Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma Y.-J. Hu 1, X.-Y. Luo 2, Y. Yang 3, C.-Y. Chen 1, Z.-Y. Zhang 4 and X. Guo 1 1 Department
More informationLYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG
LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Takehiro Watanabe, MD a Yuzo Kurita, MD b Akira Yokoyama, MD b Keiichi
More informationPrognostic value of visceral pleural invasion in resected non small cell lung cancer diagnosed by using a jet stream of saline solution
Maruyama et al General Thoracic Surgery Prognostic value of visceral pleural invasion in resected non small cell lung cancer diagnosed by using a jet stream of saline solution Riichiroh Maruyama, MD Fumihiro
More informationCell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-
Supplemental material and methods Reagents. Hydralazine was purchased from Sigma-Aldrich. Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC- 133, human thyroid medullary
More informationCorrelation between survivin expression and prognosis in non-small cell lung cancer
Respiratory Medicine (2006) 100, 2220 2226 Correlation between survivin expression and prognosis in non-small cell lung cancer Sükran Atikcan a, Ebru Ünsal a,, Funda Demirag b, Deniz Köksal a, Aydın Yilmaz
More informationStudy on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value
Study on the expression of MMP-9 and NF-κB proteins in epithelial ovarian cancer tissue and their clinical value Shen Wei 1,a, Chen Juan 2, Li Xiurong 1 and Yin Jie 1 1 Department of Obstetrics and Gynecology,
More informationClinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients
Yonago Acta medica 2012;55:57 61 Clinicopathologic Characteristics and Prognosis of Gastric Cancer in Young Patients Hiroaki Saito, Seigo Takaya, Yoji Fukumoto, Tomohiro Osaki, Shigeru Tatebe and Masahide
More informationLong-Term Outcome and Late Recurrence in Patients with Completely Resected Stage IA Non-small Cell Lung Cancer
ORIGINAL ARTICLE Long-Term Outcome and Late Recurrence in Patients with Completely Resected Stage IA Non-small Cell Lung Cancer Ryo Maeda, MD,* Junji Yoshida, MD,* Genichiro Ishii, MD, Keiju Aokage, MD,*
More informationEvaluation of cyclin-dependent kinase inhibitor p27 and Bcl-2 protein in nonsmall cell lung cancer
166 Turkish Journal of Cancer Volume 35, No.4, 2005 Evaluation of cyclin-dependent kinase inhibitor p27 and cl-2 protein in nonsmall cell lung cancer LEVENT DERTS Z 1, GÜLY ÖZ L M 2, LKNUR KÜKNER 2, REM
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationImplications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers
日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu
More informationBasaloid Carcinoma of the Lung: A Really Dismal Histologic Variant?
Carcinoma of the Lung: A Really Dismal Histologic Variant? Dae Joon Kim, MD, Kil Dong Kim, MD, Dong Hwan Shin, MD, Jae Y Ro, MD, and Kyung Young Chung, MD Departments of Thoracic and Cardiovascular Surgery,
More informationLung cancer is the leading cause of cancer death in the
Arterial Invasion Predicts Early Mortality in Stage I Non Small Cell Lung Cancer Taine T. V. Pechet, MD, Shamus R. Carr, MD, Joshua E. Collins, BS, Herbert E. Cohn, MD, and John L. Farber, MD Division
More informationSurvival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy
Survival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L. Chen, MD, MBA, Cindy Yu, MD, and Royce
More informationIn 1989, Deslauriers et al. 1 described intrapulmonary metastasis
ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,
More informationThe roles of adjuvant chemotherapy and thoracic irradiation
Factors Predicting Patterns of Recurrence After Resection of N1 Non-Small Cell Lung Carcinoma Timothy E. Sawyer, MD, James A. Bonner, MD, Perry M. Gould, MD, Robert L. Foote, MD, Claude Deschamps, MD,
More informationThe prognostic significance of central fibrosis of adenocarcinoma
Prognostic Significance of the Size of Central Fibrosis in Peripheral Adenocarcinoma of the Lung Kenji Suzuki, MD, Tomoyuki Yokose, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, Kenro Takahashi, MD, Kanji
More informationUpstaging by Vessel Invasion Improves the Pathology Staging System of Non- Small Cell Lung Cancer*
CHEST Original Research Upstaging by Vessel Invasion Improves the Pathology Staging System of Non- Small Cell Lung Cancer* Tomoshi Tsuchiya, MD, PhD; Satoshi Hashizume, MD; Shinji Akamine, MD, PhD; Masashi
More informationT3 NSCLC: Chest Wall, Diaphragm, Mediastinum
for T3 NSCLC: Chest Wall, Diaphragm, Mediastinum AATS Postgraduate Course April 29, 2012 Thomas A. D Amico MD Professor of Surgery, Chief of Thoracic Surgery Duke University Health System Disclosure No
More informationSupplementary Figure 1. HOPX is hypermethylated in NPC. (a) Methylation levels of HOPX in Normal (n = 24) and NPC (n = 24) tissues from the
Supplementary Figure 1. HOPX is hypermethylated in NPC. (a) Methylation levels of HOPX in Normal (n = 24) and NPC (n = 24) tissues from the genome-wide methylation microarray data. Mean ± s.d.; Student
More informationSignificance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories
Original Article Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories Wu Song, Yulong He, Shaochuan Wang, Weiling
More informationPleural lavage cytology as an independent prognostic factor in non-small cell lung cancer patients with stage I disease and adenocarcinoma
244 Pleural lavage cytology as an independent prognostic factor in non-small cell lung cancer patients with stage I disease and adenocarcinoma DAISUKE HOKKA 1, KAZUYA UCHINO 2, KENTA TANE 2, HIROYUKI OGAWA
More informationPerigastric lymph node metastases in gastric cancer: comparison of different staging systems
Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems
More informationIn the mid 1970s, visceral pleural invasion (VPI) was included
ORIGINAL ARTICLE Tumor Invasion of Extralobar Soft Tissue Beyond the Hilar Region Does Not Affect the Prognosis of Surgically Resected Lung Cancer Patients Hajime Otsuka, MD,* Genichiro Ishii, MD, PhD,*
More informationStandard treatment for pulmonary metastasis of non-small
ORIGINAL ARTICLE Resection of Pulmonary Metastasis of Non-small Cell Lung Cancer Kenichi Okubo, MD,* Toru Bando, MD,* Ryo Miyahara, MD,* Hiroaki Sakai, MD,* Tsuyoshi Shoji, MD,* Makoto Sonobe, MD,* Takuji
More informationSmall cell lung cancer (SCLC), which represents 20%
ORIGINAL ARTICLES: GENERAL THORACIC Surgical Results for Small Cell Lung Cancer Based on the New TNM Staging System Masayoshi Inoue, MD, Shinichiro Miyoshi, MD, Tsutomu Yasumitsu, MD, Takashi Mori, MD,
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationClinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer
Original Article Clinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer Jun Zhao*, Jiagen Li*, Ning Li, Shugeng Gao Department of Thoracic Surgery, National
More informationThyroid Cancer: When to Treat? MEGAN R. HAYMART, MD
Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF MICHIGAN MICHIGAN AACE 2018 ANNUAL MEETING Thyroid Cancer: When Not to Treat? FOCUS WILL BE ON LOW-RISK
More informationPulmonary resection remains the most effective. Survival in Synchronous vs Single Lung Cancer. Upstaging Better Reflects Prognosis
Survival in Synchronous vs Single Lung Cancer Upstaging Better Reflects Prognosis Marcel Th. M. van Rens, MD; Pieter Zanen, MD, PhD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD;
More informationWHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER?
CANCER STAGING TNM and prognosis in CRC WHAT SHOULD WE DO WITH TUMOUR BUDDING IN EARLY COLORECTAL CANCER? Alessandro Lugli, MD Institute of Pathology University of Bern Switzerland Maastricht, June 19
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationCitation Acta Medica Nagasakiensia. 1992, 37
NAOSITE: Nagasaki University's Ac Title Author(s) A Study on the Expression of EGFR a Content in the Stomach Cancer Tissu Nakazaki Takayuki Citation Acta Medica Nagasakiensia. 1992 37 Issue Date 1992-12-25
More informationStage IB Nonsmall Cell Lung Cancers: Are They All the Same?
ORIGINAL ARTICLES: GENERAL THORACIC GENERAL THORACIC SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article,
More informationThe T4 category of lung cancer is defined by invasion of the
Original Article Results of T4 Surgical Cases in the Japanese Lung Cancer Registry Study Should Mediastinal Fat Tissue Invasion Really be Included in the T4 Category? Shun-ichi Watanabe, MD,* Hisao Asamura,
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationVisceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size
GENERAL THORACIC Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD, Neda Kalhor, MD, Wayne L. Hofstetter,
More informationA comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer
European Journal of Cardio-Thoracic Surgery 49 (2016) 580 588 doi:10.1093/ejcts/ezv134 Advance Access publication 18 April 2015 ORIGINAL ARTICLE Cite this article as: Lee GD, Kim DK, Moon DH, Joo S, Hwang
More informationTumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma
ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI
More informationRESEARCH ARTICLE. Masaki Tomita 1, Takanori Ayabe 1, Eiichi Chosa 1, Naohiro Nose 1, Kunihide Nakamura 2 * Abstract. Introduction
RESEARCH ARTICLE Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer Masaki Tomita 1, Takanori
More informationPrognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients
1 Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan 2 Department of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East,
More informationPrognostic Significance of HER-2/neu Overexpression in Stage I Adenocarcinoma of Lung
Prognostic Significance of HER-2/neu Overexpression in Stage I Adenocarcinoma of Lung Chih-Cheng Hsieh, MD, Kuan-Chih Chow, PhD, Huei-Jyh Fahn, MD, Chun-Ming Tsai, MD, Wing-Yin Li, MD, Min-Hsiung Huang,
More informationLung cancer is now a major cause of death in developed
Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,
More informationTitle page. Title: MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in
Title page Title: MicroRNA- Controls Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma Authors Manabu Mikamori, Daisaku Yamada, Hidetoshi Eguchi, Shinichiro Hasegawa, Tomoya
More informationA ngiogenesis is essential for tumour growth and
965 ORIGINAL ARTICLE CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer W Hilbe, S Dirnhofer, F Oberwasserlechner, T Schmid, E Gunsilius, G Hilbe,
More informationLymph node metastasis is the most important prognostic
ORIGINAL ARTICLE Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and III-Tubulin Between Primary Non-small Cell Lung Cancer
More informationSupplementary Fig. 1: ATM is phosphorylated in HER2 breast cancer cell lines. (A) ATM is phosphorylated in SKBR3 cells depending on ATM and HER2
Supplementary Fig. 1: ATM is phosphorylated in HER2 breast cancer cell lines. (A) ATM is phosphorylated in SKBR3 cells depending on ATM and HER2 activity. Upper panel: Representative histograms for FACS
More informationImpact of Large Tumor Size on Survival After Resection of Pathologically Node Negative (pn0) Non Small Cell Lung Cancer
Impact of Large Tumor Size on Survival After Resection of Pathologically Node Negative (pn0) Non Small Cell Lung Cancer Shin-ichi Takeda, MD, Shimao Fukai, MD, Hikotaro Komatsu, MD, Etsuo Nemoto, MD, Kenji
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/55957 holds various files of this Leiden University dissertation Author: Dekker T.J.A. Title: Optimizing breast cancer survival models based on conventional
More informationCorrelation of Vascular Endothelial Growth Factor Expression and Neovascularization with Colorectal Carcinoma: A Pilot Study
Research Article imedpub Journals http://www.imedpub.com Journal of Adenocarcinoma Vol. 1 No. 1:5 DOI: 10.21767/2572-309X.10005 Correlation of Vascular Endothelial Growth Factor Expression and Neovascularization
More informationMEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER
MEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Hideki Akamatsu, MD a Yuzo
More informationResected Synchronous Primary Malignant Lung Tumors: A Population-Based Study
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationA biological staging model for operable non-small cell lung cancer
Thorax 2001;56:561 566 561 Department of Medical Oncology, Leicester Royal Infirmary, Leicester LE1 5WW, UK GCox A Andi K J O Byrne Department of Respiratory Medicine and Thoracic Surgery, Glenfield Hospital,
More informationOlfactomedin 4 (GW112, hgc-1) is an independent prognostic marker for survival in patients with colorectal cancer
experimental and therapeutic medicine 1: 73-78, 2010 73 Olfactomedin 4 (GW112, hgc-1) is an independent prognostic marker for survival in patients with colorectal cancer NAOTSUGU SEKO 1, NAOHIDE OUE 1,
More informationModified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast
British Journal of Cancer (2011) 105, 698 708 All rights reserved 0007 0920/11 www.bjcancer.com Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma
More informationTumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer
GENERAL THORACIC ORIGINAL ARTICLES: GENERAL THORACIC GENERAL THORACIC SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related
More informationTitle: What has changed in the surgical treatment strategies of non-small cell lung cancer in
1 Manuscript type: Original Article DOI: Title: What has changed in the surgical treatment strategies of non-small cell lung cancer in twenty years? A single centre experience Short title: Changes in the
More informationTumor Marker Expression Is Predictive of Survival in Patients With Esophageal Cancer
Tumor Marker Expression Is Predictive of Survival in Patients With Esophageal Cancer Thomas A. Aloia, MD, David H. Harpole, Jr, MD, Carolyn E. Reed, MD, Carmen Allegra, PhD, Mary-Beth H. Moore, BA, James
More informationTumour size as a prognostic factor after resection of lung carcinoma
Tumour size as a prognostic factor after resection of lung carcinoma A. S. SOORAE AND R. ABBEY SMITH Thorax, 1977, 32, 19-25 From the Cardio-Thoracic Unit, Walsgrave Hospital, Clifford Bridge Road, Coventry
More informationTNM classifications have been established for various
Lymphogenous and Hematogenous Metastasis of Thymic Epithelial Tumors Kazuya Kondo, MD, PhD, and Yasumasa Monden, MD, PhD Department of Oncological and Regenerative Surgery, School of Medicine, University
More informationTreatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer
Treatment Strategy for Patients With Surgically Discovered N2 Stage IIIA Non-Small Cell Lung Cancer Ryoichi Nakanishi, MD, Toshihiro Osaki, MD, Kozo Nakanishi, MD, Ichiro Yoshino, MD, Takashi Yoshimatsu,
More informationConcurrent Analysis of Human Equilibrative Nucleoside Transporter 1 and Ribonucleotide
1 ORIGINAL ARTICLE Concurrent Analysis of Human Equilibrative Nucleoside Transporter 1 and Ribonucleotide Reductase Subunit 1 Expression Increases Predictive Value for Prognosis in Cholangiocarcinoma Patients
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationSurgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study
Original article Annals of Gastroenterology (2013) 26, 346-352 Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study Subhankar Chakraborty
More informationThe Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC)
The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) Disclosure None Background Torino, Italy LCNC Rare tumor (2% to 3% all resected primary lung cancers) Preoperative
More informationLung cancer is the most common cause of cancer-related
Original Article Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung Tomonari Kinoshita, MD,* Takashi Ohtsuka, MD, PhD,*
More information